Search research articles
Contact Us
Filters
Showing results (261-270 of 277) with videos related to
Page
of 28
Sort By:
Scientific Reports
|
June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma
Matthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
August 14, 2025
Prone transpsoas (PTP)-LLIF approach versus standard LLIF in patients undergoing surgical revision following adult spinal deformity correction surgery
Luis D Diaz-Aguilar, Nolan J Brown, Andrew Nguyen, et al.
Neurology
|
July 29, 2024
Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome
Sara E Zsadanyi, Alejandra O Morcillo-Nieto, Mateus R Aranha, et al.
Skeletal Muscle
|
May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
Narendra Bharathy, Noah E Berlow, Eric Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2015
Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setup
Pratik Devasthale, Wei Wang, Andres S Hernandez, et al.
BMC Cancer
|
June 19, 2019
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Noah E Berlow, Rishi Rikhi, Mathew Geltzeiler, et al.
Journal of Medicinal Chemistry
|
November 2, 2007
Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180)
Jun Li, Stephanie Y Chen, James J Li, et al.
Journal of Medicinal Chemistry
|
January 24, 2017
Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode
Elizabeth A Jurica, Ximao Wu, Kristin N Williams, et al.
Journal of Medicinal Chemistry
|
January 10, 2018
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists
Jun Shi, Zhengxiang Gu, Elizabeth Anne Jurica, et al.
Science Signaling
|
November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma
Narendra Bharathy, Noah E Berlow, Eric Wang, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 277) with videos related to
Sort By:
Page
of 28
Scientific Reports
|
June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma
Matthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
August 14, 2025
Prone transpsoas (PTP)-LLIF approach versus standard LLIF in patients undergoing surgical revision following adult spinal deformity correction surgery
Luis D Diaz-Aguilar, Nolan J Brown, Andrew Nguyen, et al.
Neurology
|
July 29, 2024
Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome
Sara E Zsadanyi, Alejandra O Morcillo-Nieto, Mateus R Aranha, et al.
Skeletal Muscle
|
May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
Narendra Bharathy, Noah E Berlow, Eric Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2015
Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setup
Pratik Devasthale, Wei Wang, Andres S Hernandez, et al.
BMC Cancer
|
June 19, 2019
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Noah E Berlow, Rishi Rikhi, Mathew Geltzeiler, et al.
Journal of Medicinal Chemistry
|
November 2, 2007
Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180)
Jun Li, Stephanie Y Chen, James J Li, et al.
Journal of Medicinal Chemistry
|
January 24, 2017
Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode
Elizabeth A Jurica, Ximao Wu, Kristin N Williams, et al.
Journal of Medicinal Chemistry
|
January 10, 2018
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists
Jun Shi, Zhengxiang Gu, Elizabeth Anne Jurica, et al.
Science Signaling
|
November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma
Narendra Bharathy, Noah E Berlow, Eric Wang, et al.
Page
of 28